Trial Profile
Mesalazine for postinfective irritable bowel syndrome: pilot study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jan 2013
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.